ESC 365 - Innovative strategies for lipid lowering treatment: PCSK9 inhibition

ESC Premium Access

Innovative strategies for lipid lowering treatment: PCSK9 inhibition

Session: Innovative strategies for secondary prevention

Topic: Treatment

Speaker: Professor F. Mach (Geneva, CH)

Event: ESC Congress 2018

Congress Presentation

About the speaker

Professor Francois Mach

Geneva University Hospitals, Geneva (Switzerland)

21 presentations

2 followers

3 more presentations in this session

Anti-inflammatory therapy : interleukin-1 beta inhibition to prevent cardiovascular events

Speaker: Doctor P. Ridker (Boston, US)

Prolonged P2Y12 inhibition or Factor Xa inhibition in patients after an acute coronary syndrome

Speaker: Doctor T. Cuisset (Marseille, FR)

Balancing residual inflammatory, lipid, and thrombotic risk in coronary artery disease

Speaker: Professor P. Libby (Boston, US)

Access the full session

Innovative strategies for secondary prevention

Speakers: Professor F. Mach, Doctor P. Ridker, Doctor T. Cuisset, Professor P. Libby

About the event

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by